A series of antipyrinyl-pyrazolo[1,5-a]pyrimidines have been synthesized by reactions of aminopyrazole (4) with various formylated active proton compounds in the presence of KHSO4 (aqueous media), under ultrasound irradiation. The structures of the compounds have been established with the help of spectral and analytical data. N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide (6a) was further subjected to X-ray crystallographic studies to avoid any ambiguity of the derived structures. Crystal data for compound 6a, C51H46N12O5 (M =907.00 g/mol): triclinic, space group P-1 (no. 2), a = 9.9554(3) Å, b = 14.0875(4) Å, c = 17.4572(4) Å, α = 79.676(2)°, β = 85.283(2)°, γ = 72.647(2)°, V = 2297.97(11) Å3, Z = 2, T = 296.15 K, μ(MoKα) = 0.088 mm-1, Dcalc = 1.311 g/cm3, 29732 reflections measured (4.174° ≤ 2Θ ≤ 57.068°), 10681 unique (Rint = 0.0400, Rsigma = 0.0533) which were used in all calculations. The final R1 was 0.0566 (I > 2σ(I)) and wR2 was 0.1663 (all data). The novel compounds were also screened for their biological activities.
23 November 2022 in International Journal of Advances in Medicine
Precision medicine is poised to increasingly improve health outcomes for more people in the near future. In contrast to the more traditional reactive methods of disease treatment, precision medicine is a customizable treatment and disease prevention approach that is tailored for the individual. Artificial intelligence (AI) using sophisticated algorithms and machine learning (ML) tools powers these precision medicine processes. These algorithms analyze big data collected from multiple sources over the past decades to aid physicians to make data-backed critical clinical decisions. However, studies have shown that unintentional biases in the source data and in the process can affect these precision medicine efforts.
10 September 2020 in International Journal of Current Microbiology and Applied Sciences